The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
The latest report by IMARC, titled “ BloodCultureTestMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandForecast20 23-2028
” the global blood culture test market size reached US$ 4.7 Billion in 2022.
A blood culture test is used to check foreign invaders like yeast, bacteria, and other microorganisms in the blood. It relies on the blood sample of an individual obtained via sterile technique, which is kept in culture media and incubated in a controlled environment for a few days. the results help in determining the pathogens causing the infection and possible methods for combating the disease.
Request Free Sample Report: https://www.imarcgroup.com/blood-culture-test-market/requestsample
The global market is primarily driven by the rising incidences of bloodstream infections (BSI), sepsis and environmentborne diseases. Besides this, the increasing prevalence of chronic diseases, especially among the geriatric population, which is relatively more prone to medical ailments, is also contributing to the market growth. Furthermore, leading players are focusing on launching novel diagnostic techniques to reduce diagnosis time, eliminate manual errors and offer early prevention of infections.
This, along with the increased cases of coronavirus disease (COVID-19) during the year 2020 and 2021, has escalated the demand for blood culture tests. Looking forward, the market value is projected to reach US$ 7.7 Billion by 2028, expanding at a CAGR of 8.5% during the forecast period (2023-2028).
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
MarketSummary:
BreakupbyTestingMethod:
• Conventional
• Automated
BreakupbyProduct:
• Consumables
• Blood Culture Media
• Assay Kits and Reagents
• Blood Culture Accessories
• Instruments
• Automated Blood Culture Systems
• Supporting Laboratory Equipment
• Software and Services
BreakupbyTechnology:
• Culture-based Technology
• Molecular Technology
• Microarray
• PCR
• PNA-FISH
• Proteomic Technology
• Others
BreakupbyApplication:
• Bacterial Infections
• Fungal Infections
• Mycobacterial Infections
BreakupbyEnd-User:
• Hospital Laboratories
• Reference Laboratories
• Research Laboratories
• Others
BreakupbyRegion:
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
CompetitiveLandscapewithKeyPlayers:
• Abbott Laboratories
• Danaher Corporation
• Becton
• Dickinson and Company
• bioMeriux SA
• Bruker Corporation
• Luminex Corporation
• Merck KGaA
• Siemens Healthcare GmbH
• F.Hoffmann-La Roche Ltd.
• T2 Biosystems Inc.
• Thermo Fisher Scientific Company
ViewFullReportwithTOC&ListofFigure:https://www.imarcgroup.com/blood-culture-test-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
